These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34734257)

  • 1. Urban Particulate Matter Impairment of Airway Surface Liquid-Mediated Coronavirus Inactivation.
    Stapleton EM; Welch JL; Ubeda EA; Xiang J; Zabner J; Thornell IM; Nonnenmann MW; Stapleton JT; Comellas AP
    J Infect Dis; 2022 Jan; 225(2):214-218. PubMed ID: 34734257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme® a medical device mouth spray against the common cold.
    Gudmundsdottir Á; Scheving R; Lindberg F; Stefansson B
    J Med Virol; 2021 Mar; 93(3):1792-1795. PubMed ID: 32975843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.
    Signer J; Jonsdottir HR; Albrich WC; Strasser M; Züst R; Ryter S; Ackermann-Gäumann R; Lenz N; Siegrist D; Suter A; Schoop R; Engler OB
    Virol J; 2020 Sep; 17(1):136. PubMed ID: 32907596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease Inhibitors: Candidate Drugs to Inhibit Severe Acute Respiratory Syndrome Coronavirus 2 Replication.
    Yamaya M; Nishimura H; Deng X; Kikuchi A; Nagatomi R
    Tohoku J Exp Med; 2020 May; 251(1):27-30. PubMed ID: 32448818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway.
    Ma Q; Li R; Pan W; Huang W; Liu B; Xie Y; Wang Z; Li C; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Hui M; Fu L; Yang Z
    Phytomedicine; 2020 Nov; 78():153296. PubMed ID: 32890913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Antiviral Coatings for High-Touch Surfaces by Using Human Coronaviruses HCoV-229E and SARS-CoV-2.
    Butot S; Baert L; Zuber S
    Appl Environ Microbiol; 2021 Sep; 87(19):e0109821. PubMed ID: 34288707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct Quantitation of SARS-CoV-2 Virus in Urban Ambient Air via a Continuous-Flow Electrochemical Bioassay.
    Jiang F; Liu B; Yue Y; Tao Y; Xiao Z; Li M; Ji Z; Tang J; Qiu G; Spillmann M; Cao J; Zhang L; Wang J
    Adv Sci (Weinh); 2023 Aug; 10(22):e2301222. PubMed ID: 37222069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteolin Isolated from
    Hakem A; Desmarets L; Sahli R; Malek RB; Camuzet C; François N; Lefèvre G; Samaillie J; Moureu S; Sahpaz S; Belouzard S; Ksouri R; Séron K; Rivière C
    Molecules; 2023 May; 28(11):. PubMed ID: 37298740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Good and bad get together: Inactivation of SARS-CoV-2 in particulate matter pollution from different fuels.
    de la Fuente J; Armas O; Barroso-Arévalo S; Gortázar C; García-Seco T; Buendía-Andrés A; Villanueva F; Soriano JA; Mazuecos L; Vaz-Rodrigues R; García-Contreras R; García A; Monsalve-Serrano J; Domínguez L; Sánchez-Vizcaíno JM
    Sci Total Environ; 2022 Oct; 844():157241. PubMed ID: 35817121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Evolution of Human Coronavirus 229E in Hong Kong and a Fatal COVID-19 Case Involving Coinfection with a Novel Human Coronavirus 229E Genogroup.
    Lau SKP; Lung DC; Wong EYM; Aw-Yong KL; Wong ACP; Luk HKH; Li KSM; Fung J; Chan TTY; Tang JYM; Zhu L; Yip CCY; Wong SCY; Lee RA; Tsang OTY; Yuen KY; Woo PCY
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33568452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon regulatory factor 3 mediates effective antiviral responses to human coronavirus 229E and OC43 infection.
    Duncan JKS; Xu D; Licursi M; Joyce MA; Saffran HA; Liu K; Gohda J; Tyrrell DL; Kawaguchi Y; Hirasawa K
    Front Immunol; 2023; 14():930086. PubMed ID: 37197656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of an antimicrobial surface coating against human coronavirus 229E and SARS-CoV-2.
    Ikner LA; Torrey JR; Gundy PM; Gerba CP
    Am J Infect Control; 2021 Dec; 49(12):1569-1571. PubMed ID: 34499978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal Lactoferrin Exerts Antiviral Activity against HCoV-229E and SARS-CoV-2 Pseudoviruses In Vitro.
    Andreu S; Ripa I; Bello-Morales R; López-Guerrero JA
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 in Atmospheric Particulate Matter: An Experimental Survey in the Province of Venice in Northern Italy.
    Pivato A; Formenton G; Di Maria F; Baldovin T; Amoruso I; Bonato T; Mancini P; Bonanno Ferraro G; Veneri C; Iaconelli M; Bonadonna L; Vicenza T; La Rosa G; Suffredini E
    Int J Environ Res Public Health; 2022 Aug; 19(15):. PubMed ID: 35954818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overinterpretation of the antiviral results for human coronavirus strain 229E (HCoV-229E) relative to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
    Shewale JG; Ratcliff JL
    J Med Virol; 2021 Apr; 93(4):1900-1902. PubMed ID: 33368396
    [No Abstract]   [Full Text] [Related]  

  • 16. PM10 promotes an inflammatory cytokine response that may impact SARS-CoV-2 replication
    Marín-Palma D; Tabares-Guevara JH; Zapata-Cardona MI; Zapata-Builes W; Taborda N; Rugeles MT; Hernandez JC
    Front Immunol; 2023; 14():1161135. PubMed ID: 37180105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robust Evaluation of Ultraviolet-C Sensitivity for SARS-CoV-2 and Surrogate Coronaviruses.
    Boegel SJ; Gabriel M; Sasges M; Petri B; D'Agostino MR; Zhang A; Ang JC; Miller MS; Meunier SM; Aucoin MG
    Microbiol Spectr; 2021 Oct; 9(2):e0053721. PubMed ID: 34668746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lichen or Associated Micro-Organism Compounds Are Active against Human Coronaviruses.
    Desmarets L; Millot M; Chollet-Krugler M; Boustie J; Camuzet C; François N; Rouillé Y; Belouzard S; Tomasi S; Mambu L; Séron K
    Viruses; 2023 Aug; 15(9):. PubMed ID: 37766264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Air pollution particulate matter as a potential carrier of SARS-CoV-2 to the nervous system and/or neurological symptom enhancer: arguments in favor.
    Borisova T; Komisarenko S
    Environ Sci Pollut Res Int; 2021 Aug; 28(30):40371-40377. PubMed ID: 33051841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental pollution and COVID-19: the molecular terms and predominant disease outcomes of their sweetheart agreement.
    Colacci A; Bortone G; Maffei G; Marchesi S; Mescoli A; Parmagnani F; Pillo G; Ranzi A; Rotondo F; Serra S; Vaccari M; Zauli Sajani S; Mascolo MG; Jacobs MN
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):169-182. PubMed ID: 33412808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.